Follow
Viveksagar Krishnamurthy Radhakrishna
Viveksagar Krishnamurthy Radhakrishna
Other namesVivek Sagar
Novartis Institutes for Biomedical Research
Verified email at novartis.com
Title
Cited by
Cited by
Year
Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition
AN Hata, MJ Niederst, HL Archibald, M Gomez-Caraballo, FM Siddiqui, ...
Nature medicine 22 (3), 262-269, 2016
9102016
Studying clonal dynamics in response to cancer therapy using high-complexity barcoding
HC Bhang, DA Ruddy, V Krishnamurthy Radhakrishna, JX Caushi, ...
Nature medicine 21 (5), 440-448, 2015
5212015
Genomic analysis of nasopharyngeal carcinoma reveals TME-based subtypes
L Zhang, KD MacIsaac, T Zhou, PY Huang, C Xin, JR Dobson, K Yu, ...
Molecular Cancer Research 15 (12), 1722-1732, 2017
1302017
PISCES: a package for rapid quantitation and quality control of large scale mRNA-seq datasets
MD Shirley, VK Radhakrishna, J Golji, JM Korn
bioRxiv, 2020.12. 01.390575, 2020
52020
The OHANA Project: Target Cancer, One Cell at a Time
D Ruddy, A Liss, V Cremasco, J Harrison, J Chang, S Dimitrieva, M Piquet, ...
PANCREAS 50 (7), 1093-1093, 2021
2021
Abstract PO-100: Expressed molecular barcoding coupled with single cell RNAseq enables a high resolution investigation into the evolution of drug tolerance
JL Cotton, VK Radhakrishna, JE Diez, DA Ruddy, K Sprouffske, G Boulay, ...
Cancer Research 80 (21_Supplement), PO-100-PO-100, 2020
2020
Expressed molecular barcoding coupled with single cell RNAseq enables a high resolution investigation into the evolution of drug tolerance.
JL Cotton, VK Radhakrishna, JE Diez, DA Ruddy, K Sprouffske, G Boulay, ...
CANCER RESEARCH 80 (21), 2020
2020
In vivo shRNA screens under treatment pressure by BRAF and MEK inhibitors to identify novel combination treatment strategies for BRAF-mutant colorectal cancer
HC Bhang, MT DiMare, DP Kodack, L Tan, G Kerr, VK Radhakrishna, ...
Cancer Research 79 (13_Supplement), 394-394, 2019
2019
Understanding clonal complexity of a tumor xenograft model via cellular barcoding technology
JX Caushi, HC Bhang, J Li, I Kao, V Krishnamurthy Radhakrishna, ...
Cancer Research 75 (15_Supplement), 3240-3240, 2015
2015
High complexity barcoding to study clonal dynamics in response to cancer therapy
HC Bhang, DA Ruddy, V Krishnamurthy Radhakrishna, R Zhao, I Kao, ...
Cancer Research 75 (15_Supplement), 2847-2847, 2015
2015
The system can't perform the operation now. Try again later.
Articles 1–10